The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension

Abstract

This study suggests that high doses of calcium-channel blockers in patients with primary pulmonary hypertension who respond with reductions in pulmonary-artery pressure and pulmonary vascular resistance may improve survival over a five-year period.